Search

everythinglearnresearchcommunity

for

Search:↓

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Testosterone therapy improves strength and body composition in older men with low testosterone.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The method can measure multiple hormones in women's hair and may help identify hormone-related health issues.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Older men with high total testosterone might not show symptoms, while younger men with hyperandrogenism may experience hair loss or acne.

Higher testosterone in females with PCOS is linked to depression and cognitive issues, but anti-androgen treatment can help.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Men with low testosterone or breast growth should be checked for Cushing syndrome.

The woman's symptoms and tests suggest her adrenal glands are producing too many male hormones.

DHT deficiency in rats reduces sperm content and affects testis structure over time.

Women with and without PCOS show no significant differences in psychopathic traits.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Melatonin affects when and how goat hair follicle genes turn on and off during growth cycles.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Testosterone raises blood pressure by affecting kidney function and brain gene regulation over time.